Ronil Patel
Corporate Officer/Principal bei OCUPHIRE PHARMA, INC.
Vermögen: 13 514 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Ronil Patel
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ronil Patel
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Citigroup Global Markets, Inc. (Broker)
Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Analyst-Equity | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Investment Managers | Private Equity Investor | |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kalyra Pharmaceuticals, Inc.
Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Medical/Nursing Services | Corporate Officer/Principal Chief Executive Officer | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Corporate Officer/Principal | |
Brandeis University | College/University | Graduate Degree | |
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree | |
University of Michigan | College/University | Graduate Degree Undergraduate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Politehnica University of Bucharest | College/University | Doctorate Degree | |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
David Geffen School of Medicine | College/University | Doctorate Degree | |
HEALIOS K.K. | Pharmaceuticals: Major | Director/Board Member | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Washington University School of Medicine | College/University | Corporate Officer/Principal | |
BioSavita, Inc.
BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Biotechnology | Chief Operating Officer | |
Oncternal Oncology, Inc.
Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Biotechnology | Corporate Officer/Principal | |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Director of Finance/CFO | |
jCyte, Inc.
jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director of Finance/CFO | |
ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Founder | |
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Pepose Vision Institute
Pepose Vision Institute Hospital/Nursing ManagementHealth Services Pepose Vision Institute provides LASIK surgery and dry eye treatment services. The private company is based in Chesterfield, MO. The company was founded by Jay S. Pepose. | Hospital/Nursing Management | Founder |
Statistik
International
Vereinigte Staaten | 44 |
Frankreich | 2 |
Rumänien | 2 |
Japan | 2 |
Hong Kong | 2 |
Sektoral
Health Technology | 28 |
Consumer Services | 9 |
Finance | 6 |
Health Services | 4 |
Commercial Services | 4 |
Operativ
Corporate Officer/Principal | 51 |
Director/Board Member | 49 |
Founder | 27 |
Chairman | 20 |
Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
James Manuso | 30 |
Cam Gallagher | 24 |
Mina Sooch | 23 |
Susan Benton | 15 |
Richard Rodgers | 13 |
Joseph Schachle | 11 |
Nirav Jhaveri | 10 |
Jay Pepose | 10 |
Sean Ainsworth | 9 |
Daniela Oniciu | 8 |
George Magrath | 8 |
Ash Jayagopal | 8 |
Mitchell Brigell | 6 |
Bernhard Hoffmann | 6 |
Barbara Withers | 6 |
- Börse
- Insiders
- Ronil Patel
- Unternehmensverbindungen